Harrow Statistics
NASDAQ: HROWHealth CareBiotechnology: Pharmaceutical PreparationsUSD
30.41-1.72 (-5.35%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Harrow by the numbers
Harrow has a market capitalization of $1.14 billion based on 37.53M shares outstanding. With trailing EPS of $-0.76, Harrow is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 0.9% above its 50-day average and 18.1% below its 200-day average.
Average daily trading volume is 626.20K shares, or about $19.0 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
HROW valuation vs. peer median
| Metric | HROW | Peer median | Difference |
|---|---|---|---|
| Market cap | $1.14B | $1.16B | -2% |
| Avg. volume | 626.20K | 901.39K | -31% |
Peer median across 8 companies: CMPS, GPCR, AAPG, OPK, KARD, GHRS, AMPH, MLYS.
Valuation
- Market cap
- $1.14B
- Forward P/E
- 16.26
- Price / sales (latest FY)
- 4.19
- EPS (TTM)
- $-0.76
- Shares outstanding
- 37.53M
Price and trading
- Previous close
- 32.13
- Open
- 31.95
- Day range
- 30.32 – 32.43
- 52-week range
- 25.76 – 54.85
- 52-week change
- -21.85%
- Beta
- —
- Volume
- 911.03K
- Average volume
- 626.20K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 9, 2026
Additional statistics
- Market Cap
- 1.14B
- Forward Pe
- 16.26
- Eps
- -0.76
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 54.85
- Week52 Low
- 25.76
- Avg Volume
- 626.20K
- Shares Outstanding
- 37.53M
- Ma50
- 30.14
- Ma200
- 37.14
- Earnings Date
- Nov 9, 2026
- Pct From52w High
- -44.56%
- Pct From52w Low
- 18.05%